Cubist Systematic Strategies’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-155,107
Closed -$5.2M 2942
2024
Q3
$5.2M Buy
155,107
+100,834
+186% +$3.44M 0.03% 813
2024
Q2
$1.36M Buy
+54,273
New +$1.26M 0.01% 1566
2022
Q2
Sell
-213
Closed -$5K 4346
2022
Q1
$5K Sell
213
-13,505
-98% -$409K ﹤0.01% 3506
2021
Q4
$477K Buy
+13,718
New +$435K ﹤0.01% 2483
2021
Q2
Sell
-29,266
Closed -$631K 2906
2021
Q1
$631K Buy
29,266
+7,334
+33% +$185K 0.01% 1824
2020
Q4
$472K Buy
21,932
+11,197
+104% +$272K 0.01% 1800
2020
Q3
$158K Sell
10,735
-20,358
-65% -$367K ﹤0.01% 2195
2020
Q2
$695K Sell
31,093
-5,867
-16% -$107K 0.01% 1400
2020
Q1
$522K Sell
36,960
-1,029
-3% -$15.6K 0.01% 1227
2019
Q4
$617K Buy
37,989
+16,801
+79% +$397K 0.01% 1425
2019
Q3
$741K Buy
21,188
+8,090
+62% +$385K 0.01% 1120
2019
Q2
$739K Buy
13,098
+9,856
+304% +$710K 0.01% 1213
2019
Q1
$237K Buy
+3,242
New +$224K 0.01% 1656
2018
Q1
Sell
-2,029
Closed -$204K 1820
2017
Q4
$204K Buy
+2,029
New +$149K 0.01% 1521

Other funds holding ANAB

Cubist Systematic Strategies's ANAB Position: Q4 2024 in Review

Cubist Systematic Strategies sold out of AnaptysBio (ANAB) in Q4 2024, closing a stake of 155,107 shares — an estimated $5.2M sold.

Cubist Systematic Strategies first reported a position in ANAB in Q4 2017 and held it in 14 quarters. The position peaked at $5.2M in Q3 2024. 135 funds tracked by Wall St. Rank hold ANAB as of Q4 2024.

  • Cubist Systematic Strategies reported no remaining AnaptysBio position as of Q4 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 155,107 AnaptysBio shares in Q4 2024, an estimated $5.2M.
  • Cubist Systematic Strategies first reported a position in AnaptysBio in Q4 2017 and held it in 14 quarters.
  • Cubist Systematic Strategies's AnaptysBio position peaked at $5.2M in Q3 2024.
  • 135 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2024.

Based on Cubist Systematic Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.